Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
Public ClinicalTrials.gov record NCT00412061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Placebo-controlled, Multicenter Phase III Study in Patients With Advanced Carcinoid Tumor Receiving Octreotide Depot and Everolimus 10 mg/Day or Octreotide Depot and Placebo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to evaluate whether everolimus 10 mg / day added to treatment with depot octreotide prolongs progression free survival compared to treatment with octreotide alone in patients with advanced carcinoid tumor.
Study identification
- NCT ID
- NCT00412061
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 429 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Apr 2010 (Actual)
- Completion
- Jun 2013 (Actual)
- Last update posted
- Nov 21, 2014
2006 – 2013
United States locations
- U.S. sites
- 38
- U.S. states
- 23
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona / Arizona Cancer Center Deptof Uof A/Arizona Cancer(2) | Tucson | Arizona | 85719 | — |
| Highlands Oncology Group The Center for Chest Care | Fayetteville | Arkansas | 72703 | — |
| Hematology Oncology Services of Arkansas | Little Rock | Arkansas | 72205 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Cedars Sinai Medical Center SC-2 | Los Angeles | California | 90048 | — |
| University of California at Los Angeles UCLA New SC Address | Los Angeles | California | 90095 | — |
| University of Colorado Dept. of Univ. of Colorado | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Centers Dept of Rocky Mountain (2) | Denver | Colorado | 80218 | — |
| Eastern Connecticut Hematology & Oncology Associates Dept. of ECHO | Norwich | Connecticut | 06360 | — |
| Cancer Centers of Connecticut Southington Location | Southington | Connecticut | 06489 | — |
| Hematology Oncology PC Dept.of Hematology Oncology(2) | Stamford | Connecticut | 06902 | — |
| Ocala Oncology Center Dept. of Ocala Oncology Center | Ocala | Florida | 34471 | — |
| Cancer Care and Hematology Specialists of Chicagoland Niles | Niles | Illinois | 60714 | — |
| Indiana University Dept.of IndianaUniv.CancerCtr | Indianapolis | Indiana | 46202 | — |
| Central Indiana Cancer Centers CICC - South | Indianapolis | Indiana | 46227 | — |
| University of Iowa Medical Center Internal Medicine | Iowa City | Iowa | 52242 | — |
| University of Kansas Cancer Center Deptof Uof Kansas CancerCenter | Kansas City | Kansas | 66160 | — |
| Kansas City Cancer Center KCCC Business Office | Overland Park | Kansas | 66210 | — |
| Norton Cancer Institute Clinical Research Program | Louisville | Kentucky | 40202 | — |
| LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Deptof LSU Health Sciences (2) | New Orleans | Louisiana | 70112 | — |
| Mayo Clinic - Rochester Division of Hematology | Rochester | Minnesota | 55905 | — |
| Washington University School Of Medicine-Siteman Cancer Ctr Division of Oncology | St Louis | Missouri | 63110 | — |
| The Center for Cancer Care and Research | St Louis | Missouri | 63141 | — |
| Dartmouth Hitchcock Medical Center Medical Oncology | Lebanon | New Hampshire | 03756 | — |
| New York Oncology Hematology, P.C. Dept. of New York Oncology. PC | Albany | New York | 12206 | — |
| New York University Medical Center NYU Medical Center (2) | New York | New York | 10016 | — |
| Duke University Medical Center Dept. of Duke Cancer Center | Durham | North Carolina | 27710 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2497 | — |
| Cancer Centers of the Carolinas CC of C -Eastside | Greenville | South Carolina | 29615 | — |
| Texas Oncology, P.A. Central Austin Cancer Center | Austin | Texas | 78731 | — |
| South Texas Institute of Cancer S. Tex Inst.- Corpus Christi | Corpus Christi | Texas | 78405 | — |
| Sammons Cancer Center - Texas Oncology Sammons Cancer Center (SC) | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A. Forth Worth -- 12th Avenue | Fort Worth | Texas | 76104 | — |
| University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology | Houston | Texas | 77030 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Virginia Oncology Associates VOA - Lake Wright | Norfolk | Virginia | 23502 | — |
| Northwest Cancer Specialists Compass Oncology -BKM | Vancouver | Washington | 98684 | — |
| University of Wisconsin / Paul P. Carbone Comp Cancer Center GI Oncology Research Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00412061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 21, 2014 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00412061 live on ClinicalTrials.gov.